Al Furqan Islamic English Medium School- For the best of both Worlds

Mangaluru, Feb 8: Professional services company Cognizant on Friday opened a new facility in Mangaluru, expanding its presence in Karnataka. Located in the heart of the city, the new 100,000 sq- ft facility can accommodate more than 1,100 employees, the NASDAQ-listed company said in a statement.

Cognizant has had an association with Mangaluru since 2011 when it acquired CoreLogic Global Services Private Limited (CoreLogic India), the India-based captive operations of CoreLogic, one of the largest real estate information and analytics provider in the US market.

From its existing centre in Mangaluru, Cognizant provides consulting, enterprise applications and business process services in the area of mortgage processing covering property taxes, research and investigations, property data warehousing and management of geospatial data.

The company currently employs more than 600 professionals in Mangaluru, more than 50 per cent of whom are women.

In addition to experienced professionals, Cognizant also hires fresh graduates for its Mangaluru centre from leading institutions such as Sahyadari Institute of Technology and Management, Manipal Institute of Technology, N.M.A.M. Institute of Technology, St Joseph's College of Engineering, Canara Engineering College, N.I.T.K. Surathkal, PA College of Engineering and Srinivas College of Engineering, as mortgage origination and servicing specialists, business analysts, consultants, automation specialists and software engineers.

In Karnataka, Cognizant also has operations in Bengaluru and Mysuru. The company has more than 28,000 professionals in Bengaluru and nearly 700 professionals in Mysuru.

States and union territories of India, Service companies, Rail transport in Karnataka, Cognizant, Dun & Bradstreet, Teaneck, New Jersey,Transport in Karnataka, Transport in Mangalore, Mangalore, Karnataka, Udupi railway station, Mangalore Junction railway station, St Joseph's College of Engineering, Sahyadari Institute of Technology, CoreLogic Global Services Private Limited, Canara Engineering College, Srinivas College of Engineering,real estate information, PA College of Engineering, N.M.A.M. Institute of Technology, st joseph's, N.I.T.K. Surathkal, Manipal Institute of Technology, software engineers, United States, business process services, mortgage processing, Institute of Technology

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.

Bengaluru, Mar 4: With details of the Bengaluru links of the Covid-19-positive patient from Hyderabad emerging, state health authorities on Tuesday got down to tracking any infection trail he may have left behind before heading home.

Schools from southeast Bengaluru asked parents to send students with masks and hand sanitizers or keep them at home if they had fever. Medical shops in Bengaluru reported panic buying of masks and hand sanitizers.

Two persons with no symptoms — the Hyderabad man’s flatmate in city, and a colleague — reported at Rajiv Gandhi Institute of Chest Diseases and put under watch at the isolation ward. Their test results are expected on Wednesday.

The authorities tracked down 71 people who had come in contact with the Hyderabad man and put them under surveillance. The 24-year-old techie had travelled to Dubai for work on February 15 and returned to Bengaluru on February 20. He attended work on February 20 and 21 before taking a bus to Hyderabad. His flat has been sealed for sanitizing.

According to Telangana officials, at least 36 of the 88 people who came in contact with the techie are showing some symptoms of Covid-19.

Contrary to reports, the infected person was not tested at the KIA since guidelines don’t say flyers from Dubai must be screened. WHO guidelines say identification of the infected person should not be revealed. However, WhatsApp groups were flooded with messages on where the infected person lived and details of his flatmate.